HOME › DRUGS › CANGRELOR
ACTIVE SUBSTANCE / INN

CANGRELOR

Brand name(s): Kengrexal, CANGRELOR, KENGREAL
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Acute Coronary Syndrome;Vascular Surgical Procedures
NDA204958
ACTIVE SUBSTANCE
Cangrelor
REGULATORS
FDA · EMA
SPONSORS / MAH
CHIESI, Chiesi Farmaceutici S.p.A., GLAND
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
KENGREALNDA204958CHIESIPrescription
CANGRELORANDA213551GLANDPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
KengrexalChiesi Farmaceutici S.p.A.Authorised23/03/2015Acute Coronary Syndrome;Vascular Surgical Procedures

FULL INTELLIGENCE ON CANGRELOR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →